Evidence map›Paper›PMID 10194481›Full record

ArticleThe Journal of clinical investigation1999

Regulation of TH1- and TH2-type cytokine expression and action in atopic asthmatic sensitized airway smooth muscle.

H Hakonarson, N Maskeri, C Carter, M M Grunstein

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 131 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. T-bet is induced by interferon-γ to mediate chemokine secretion and migration in human airway smooth muscle cells.American journal of physiology. Lung cellular and molecular physiology · 2011
    Article
  15. Article
  16. Article
  17. Article
  18. Current status and challenges of cytokine pharmacology.British journal of pharmacology · 2009
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

H HakonarsonDivision of Pulmonary Medicine, Joseph Stokes, Jr., Research Institute, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
N Maskeri
C Carter
M M Grunstein
University of Pennsylvania · USChildren's Hospital of Philadelphia · US

Funding

MATURATION OF NONSPECIFIC AIRWAYS REACTIVITYR01HL031467 · NHLBI · NATIONAL JEWISH HEALTH · PI GRUNSTEIN, MICHAEL MATEIU · 1985 to 2007
$1.9M
SIGNAL TRANSDUCTION IN SENSITIZED AIRWAY SMOOTH MUSCLER01HL058245 · NHLBI · CHILDREN'S HOSPITAL OF PHILADELPHIA · PI GRUNSTEIN, MICHAEL MATEIU · 1998 to 2002
$916k
NHLBI NIH HHS HL-31467NHLBI NIH HHS HL-58245NHLBI NIH HHS R01 HL031467
6 · The paper itself

Abstract

CD4(+) T helper (TH)1- and TH2-type cytokines reportedly play an important role in the pathobiology of asthma. Recent evidence suggests that proasthmatic changes in airway smooth muscle (ASM) responsiveness may be induced by the autocrine release of certain proinflammatory cytokines by the ASM itself. We examined whether TH1- and TH2-type cytokines are expressed by atopic asthmatic sensitized ASM and serve to autologously regulate the proasthmatic phenotype in the sensitized ASM. Expression of these cytokines and their receptors was examined in isolated rabbit and human ASM tissues and cultured cells passively sensitized with sera from atopic asthmatic patients or control subjects. Relative to controls, atopic sensitized ASM cells exhibited an early increased mRNA expression of the TH2-type cytokines, interleukin-5 (IL-5) and granulocyte-macrophage colony-stimulating factor (GM-CSF), and their receptors. This was later followed by enhanced mRNA expression of the TH1-type cytokines, IL-2, IL-12, and interferon-gamma (IFN-gamma), as well as their respective receptors. In experiments on isolated ASM tissue segments (a) exogenous administration of IL-2 and IFN-gamma to atopic asthmatic serum-sensitized ASM ablated both their enhanced constrictor responsiveness to acetylcholine (ACh) and their attenuated relaxation responsiveness to beta-adrenoceptor stimulation with isoproterenol, and (b) administration of IL-5 and GM-CSF to naive ASM induced significant increases in their contractility to ACh and impaired their relaxant responsiveness to isoproterenol. Collectively, these observations provide new evidence demonstrating that human ASM endogenously expresses both TH1- and TH2-type cytokines and their receptors, that these molecules are sequentially upregulated in the atopic asthmatic sensitized state, and that they act to downregulate and upregulate proasthmatic perturbations in ASM responsiveness, respectively.

Indexed as

AcetylcholineAnimalsAsthmaCells, CulturedCytokinesGene Expression RegulationGranulocyte-Macrophage Colony-Stimulating FactorHumansHypersensitivity, ImmediateInterferon-gammaInterleukinsIsoproterenolMuscle ContractionMuscle, SmoothRabbitsReceptors, Granulocyte-Macrophage Colony-Stimulating FactorAcetylcholineCytokinesGranulocyte-Macrophage Colony-Stimulating FactorInterferon-gammaInterleukinsIsoproterenolReceptors, Granulocyte-Macrophage Colony-Stimulating FactorReceptors, InterferonReceptors, InterleukinRNA, Messenger

Identifiers

PMID10194481
PMCPMC408262
OpenAlexW2170772872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.